Ruigrok, Eline A. M.
Verhoeven, Marjolein
Konijnenberg, Mark W.
de Blois, Erik
de Ridder, Corrina M. A.
Stuurman, Debra C.
Bertarione, Luisa
Rolfo, Katia
de Jong, Marion
Dalm, Simone U. http://orcid.org/0000-0002-6393-6901
Funding for this research was provided by:
Advanced Accelerator Applications
Article History
Received: 6 May 2022
Accepted: 25 July 2022
First Online: 11 August 2022
Declarations
:
: Financial interests: L.B. and K.R. are employed by Advanced Accelerators Applications, a Novartis Company. The other authors have no relevant financial or non-financial interests to disclose.
: The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
: All conducted animal experiments were approved by the Erasmus MC Animal Welfare Committee and were in accordance to the European law.
: Not applicable.
: Not applicable.